| |
|
|
|
ImmunoGen Inc.  
|
|
3.17 -0.03 (-0.01%) |
09-13 16:00 |
|
Open: |
3.23 |
Pre close: |
3.2 |
Target:
|
3.83 
|
|
High: |
3.275 |
Low: |
3.12 |
Resistance:
|
3.28
3.83
|
|
Volume: |
1,455,053 |
Market Cap: |
475M |
Support:
|
2.79
2.49
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.12
|
MACD |
MACD(12,26):
|
0.15 |
|
MA(20): |
2.80 |
Signal(12,26,9): |
0.11 |
|
MA(100): |
2.43 |
Stochastic Oscillator |
%K(14,3):
|
92.47  |
|
MA(250): |
4.10 |
%D(3): |
94.04 |
|
Average Volume(K) |
3-Month: |
244319
|
52-Week |
High:
|
9.84 |
|
10-Days: |
130904 |
Low: |
1.76 |
|
RSI |
RSI(14):
|
69.89 |
Change(%): |
-64.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.190 |
Return on Equity (ttm) |
-1673.0 |
Shares Out. (M) |
149.53 |
|
EPS Est. Current Year |
-0.720 |
Return on Assets (ttm) |
-27.6 |
Shares Float (M) |
134.32 |
|
EPS Est. Next Year |
-1.380 |
PEG Ratio |
0.00 |
% Held by Insiders |
1.63 |
|
EPS Est. Next Quarter |
-0.240 |
Qtrly Rev. Growth |
67.4 |
% Held by Institutions |
84.48 |
|
Forward EPS |
-0.950 |
Gross Profit (p.s.) |
-0.809 |
Shares Short (K) |
6920 |
|
Book Value (p.s.) |
-0.460 |
EBITDA (p.s.) |
-0.954 |
P/E |
-2.66 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-6.89 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-101.95 |
P/S |
1436394240.00 |
|
Operating Margin |
-304.28 |
Levered Free Cash Flow
(M) |
-75.80 |
P/CF |
-4.65 |
|
|
|
|
|
|
